Global Postoperative Nausea and Vomiting (PONV) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
SCOPE OF THE REPORT:
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
The global Postoperative Nausea and Vomiting (PONV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Postoperative Nausea and Vomiting (PONV).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Postoperative Nausea and Vomiting (PONV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Postoperative Nausea and Vomiting (PONV) market by product type and applications/end industries.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
The global Postoperative Nausea and Vomiting (PONV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Postoperative Nausea and Vomiting (PONV).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Postoperative Nausea and Vomiting (PONV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Postoperative Nausea and Vomiting (PONV) market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Acacia Pharma
- F. Hoffmann-La Roche
- Novartis
- Ani Pharmaceuticals
- Camurus
- Sanofi
- Helsinn Holding
- Eisai
- Merck
- GlaxoSmithKline
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- NK-1 Receptor Antagonists
- Others
- Non-pharmacologic Treatment
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies and Drug Stores
1 POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET OVERVIEW
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV)
1.2 Classification of Postoperative Nausea and Vomiting (PONV) by Types
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Comparison by Types (2017-2023)
1.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017
1.2.3 Serotonin Antagonists
1.2.4 Steroids
1.2.5 Dopamine Antagonists
1.2.6 NK-1 Receptor Antagonists
1.2.7 Others
1.2.8 Non-pharmacologic Treatment
1.3 Global Postoperative Nausea and Vomiting (PONV) Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Global Postoperative Nausea and Vomiting (PONV) Market by Regions
1.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.5 Global Market Size of Postoperative Nausea and Vomiting (PONV) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Acacia Pharma
2.1.1 Business Overview
2.1.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ani Pharmaceuticals
2.4.1 Business Overview
2.4.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Camurus
2.5.1 Business Overview
2.5.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Helsinn Holding
2.7.1 Business Overview
2.7.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eisai
2.8.1 Business Overview
2.8.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET COMPETITION, BY PLAYERS
3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.2.2 Top 10 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.3 Market Competition Trend
4 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE BY REGIONS
4.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Regions
4.2 North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.3 Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.5 South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
5.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
5.2 USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5.3 Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5.4 Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6 EUROPE POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
6.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
6.2 Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.3 UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.4 France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.5 Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.6 Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
7.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
7.2 China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.3 Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.4 Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.5 India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
8.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
8.2 Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8.3 Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8.4 Colombia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE POSTOPERATIVE NAUSEA AND VOMITING (PONV) BY COUNTRIES
9.1 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.3 UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.4 Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.6 South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
10 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SEGMENT BY TYPE
10.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2013-2018)
10.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Type (2018-2023)
10.3 Serotonin Antagonists Revenue Growth Rate (2013-2023)
10.4 Steroids Revenue Growth Rate (2013-2023)
10.5 Dopamine Antagonists Revenue Growth Rate (2013-2023)
10.6 NK-1 Receptor Antagonists Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
10.8 Non-pharmacologic Treatment Revenue Growth Rate (2013-2023)
11 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SEGMENT BY APPLICATION
11.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2013-2018)
11.2 Postoperative Nausea and Vomiting (PONV) Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Online Pharmacies Revenue Growth (2013-2018)
11.5 Retail Pharmacies and Drug Stores Revenue Growth (2013-2018)
12 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE FORECAST (2018-2023)
12.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)
12.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Regions (2018-2023)
12.3 North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.4 Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.6 South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV)
1.2 Classification of Postoperative Nausea and Vomiting (PONV) by Types
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Comparison by Types (2017-2023)
1.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017
1.2.3 Serotonin Antagonists
1.2.4 Steroids
1.2.5 Dopamine Antagonists
1.2.6 NK-1 Receptor Antagonists
1.2.7 Others
1.2.8 Non-pharmacologic Treatment
1.3 Global Postoperative Nausea and Vomiting (PONV) Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Global Postoperative Nausea and Vomiting (PONV) Market by Regions
1.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)
1.5 Global Market Size of Postoperative Nausea and Vomiting (PONV) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Acacia Pharma
2.1.1 Business Overview
2.1.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ani Pharmaceuticals
2.4.1 Business Overview
2.4.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Camurus
2.5.1 Business Overview
2.5.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Helsinn Holding
2.7.1 Business Overview
2.7.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eisai
2.8.1 Business Overview
2.8.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Postoperative Nausea and Vomiting (PONV) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET COMPETITION, BY PLAYERS
3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.2.2 Top 10 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.3 Market Competition Trend
4 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE BY REGIONS
4.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Regions
4.2 North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.3 Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.5 South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
5.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
5.2 USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5.3 Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
5.4 Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6 EUROPE POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
6.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
6.2 Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.3 UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.4 France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.5 Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
6.6 Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
7.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
7.2 China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.3 Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.4 Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.5 India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA POSTOPERATIVE NAUSEA AND VOMITING (PONV) REVENUE BY COUNTRIES
8.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
8.2 Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8.3 Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
8.4 Colombia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE POSTOPERATIVE NAUSEA AND VOMITING (PONV) BY COUNTRIES
9.1 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.3 UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.4 Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
9.6 South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
10 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SEGMENT BY TYPE
10.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2013-2018)
10.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Type (2018-2023)
10.3 Serotonin Antagonists Revenue Growth Rate (2013-2023)
10.4 Steroids Revenue Growth Rate (2013-2023)
10.5 Dopamine Antagonists Revenue Growth Rate (2013-2023)
10.6 NK-1 Receptor Antagonists Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
10.8 Non-pharmacologic Treatment Revenue Growth Rate (2013-2023)
11 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SEGMENT BY APPLICATION
11.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2013-2018)
11.2 Postoperative Nausea and Vomiting (PONV) Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Online Pharmacies Revenue Growth (2013-2018)
11.5 Retail Pharmacies and Drug Stores Revenue Growth (2013-2018)
12 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE FORECAST (2018-2023)
12.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)
12.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Regions (2018-2023)
12.3 North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.4 Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.6 South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Postoperative Nausea and Vomiting (PONV) Picture
Table Product Specifications of Postoperative Nausea and Vomiting (PONV)
Table Global Postoperative Nausea and Vomiting (PONV) and Revenue (Million USD) Market Split by Product Type
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017
Figure Serotonin Antagonists Picture
Figure Steroids Picture
Figure Dopamine Antagonists Picture
Figure NK-1 Receptor Antagonists Picture
Figure Others Picture
Figure Non-pharmacologic Treatment Picture
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Application (2013-2023)
Figure Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Retail Pharmacies and Drug Stores Picture
Table Global Market Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Table Acacia Pharma Basic Information, Manufacturing Base and Competitors
Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Type and Applications
Table F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Ani Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Camurus Basic Information, Manufacturing Base and Competitors
Table Camurus Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Helsinn Holding Basic Information, Manufacturing Base and Competitors
Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Type and Applications
Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Players (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2016
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2017
Figure Global Top 5 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2017
Figure Global Top 10 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2017
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Regions (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions in 2017
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
Table North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
Table South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Colombia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Nigeria Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Type (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type in 2017
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Type (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Type (2018-2023)
Figure Global Serotonin Antagonists Revenue Growth Rate (2013-2018)
Figure Global Steroids Revenue Growth Rate (2013-2018)
Figure Global Dopamine Antagonists Revenue Growth Rate (2013-2018)
Figure Global NK-1 Receptor Antagonists Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Non-pharmacologic Treatment Revenue Growth Rate (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue by Application (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application in 2017
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Application (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies and Drug Stores Revenue Growth Rate (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Postoperative Nausea and Vomiting (PONV) Picture
Table Product Specifications of Postoperative Nausea and Vomiting (PONV)
Table Global Postoperative Nausea and Vomiting (PONV) and Revenue (Million USD) Market Split by Product Type
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017
Figure Serotonin Antagonists Picture
Figure Steroids Picture
Figure Dopamine Antagonists Picture
Figure NK-1 Receptor Antagonists Picture
Figure Others Picture
Figure Non-pharmacologic Treatment Picture
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Application (2013-2023)
Figure Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Retail Pharmacies and Drug Stores Picture
Table Global Market Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)
Table Acacia Pharma Basic Information, Manufacturing Base and Competitors
Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Type and Applications
Table F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Ani Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Camurus Basic Information, Manufacturing Base and Competitors
Table Camurus Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Helsinn Holding Basic Information, Manufacturing Base and Competitors
Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Postoperative Nausea and Vomiting (PONV) Type and Applications
Table Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Type and Applications
Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Players (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2016
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2017
Figure Global Top 5 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2017
Figure Global Top 10 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2017
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Regions (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions in 2017
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
Table North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)
Table South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Colombia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure Nigeria Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Figure South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Type (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type in 2017
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Type (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Type (2018-2023)
Figure Global Serotonin Antagonists Revenue Growth Rate (2013-2018)
Figure Global Steroids Revenue Growth Rate (2013-2018)
Figure Global Dopamine Antagonists Revenue Growth Rate (2013-2018)
Figure Global NK-1 Receptor Antagonists Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Non-pharmacologic Treatment Revenue Growth Rate (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue by Application (2013-2018)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application in 2017
Table Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Application (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies and Drug Stores Revenue Growth Rate (2013-2018)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)
